InvestorsHub Logo
Followers 19
Posts 3232
Boards Moderated 1
Alias Born 06/05/2020

Re: misiu143 post# 209098

Sunday, 05/22/2022 2:21:16 PM

Sunday, May 22, 2022 2:21:16 PM

Post# of 232952
So in being ahead in LH--I meant in trying to tailor to each patient--not a 1 size fits all like many. Obviously still some issues as w 20,000+ patients then success rate of 80-85% (his guess??) but expect that to go up with more /better grouping to distinguish each groups issue and treatment. Good stuff.

Thanks for posting that up

I would guess he would be 1st to use LL to treat LHs if approved.

Don't see how he would ever run a trial to get approval for CYDY unless there are a LOT of changes. And don't see how Cydy will ever get approval without trials being run. Most comes back to $$ and how many years and $$ gone. Even still, 4 years later, no BLA submitted. ALL the amawrecks data--even available--even acceptable by FDA--even all there and everything needed?? Still no RO test that FDA wants that was "hopefully" a new way/lab/analysis that FDA "might" accept??

Maybe if the PHII "discovery" was seen as most important by some BP then maybe partner. Have to think ALL BP now seeing LH issues and potential $$. If the BP solution and FDA approve for LH is like covid/remdesivir--we are doomed
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News